scholarly journals Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 study: A biomarker analysis and updated clinical outcomes

2017 ◽  
Vol 28 ◽  
pp. v372-v373 ◽  
Author(s):  
R. Haddad ◽  
G. Blumenschein ◽  
J. Fayette ◽  
J. Guigay ◽  
A.D. Colevas ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Clinical Outcomes ◽  
Squamous Cell ◽  
Phase 3 ◽  
Treatment Beyond Progression ◽  
Biomarker Analysis

Neoadjuvant dose‐modified docetaxel in squamous cell carcinoma of the head and neck: A phase 3 study

Oral Diseases ◽  
2020 ◽  
Vol 26 (2) ◽  
pp. 285-294
Author(s):  
Yan Sun ◽  
Wei Guo ◽  
Yuxian Bai ◽  
Minghua Ge ◽  
Chaosu Hu ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document